Industry Insight

European Pharmacopoeia EP 12.2: Digital PCR Becomes a Statutory Mainstay for CGT Mycoplasma Testing

2026-08-28 · ZZBio WeChat Official Account

Summary: EP 12.2 (mandatory from 1 April 2026) formally incorporates digital PCR into NAT methods with independent release status. This article explains the five advantages of dPCR for mycoplasma detection and its value for CGT quality control.

Read the original article on WeChat →

The full article is available in Chinese. For inquiries in English, please contact us.

Interested in digital PCR?

Contact Us